| CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy A Rodriguez-Garcia, RC Lynn, M Poussin, MA Eiva, LC Shaw, ... Nature communications 12 (1), 877, 2021 | 181 | 2021 |
| Personalized expression of bitter ‘taste’receptors in human skin L Shaw, C Mansfield, L Colquitt, C Lin, J Ferreira, J Emmetsberger, ... PloS one 13 (10), e0205322, 2018 | 43 | 2018 |
| Quantitative control of gene-engineered T-cell activity through the covalent attachment of targeting ligands to a universal immune receptor NG Minutolo, P Sharma, M Poussin, LC Shaw, DP Brown, EE Hollander, ... Journal of the American Chemical Society 142 (14), 6554-6568, 2020 | 41 | 2020 |
| Burly1 is a mouse QTL for lean body mass that maps to a 0.8-Mb region of chromosome 2 C Lin, BD Fesi, M Marquis, NP Bosak, A Lysenko, MA Koshnevisan, ... Mammalian genome 29, 325-343, 2018 | 5 | 2018 |
| Adiposity QTL Adip20 decomposes into at least four loci when dissected using congenic strains C Lin, BD Fesi, M Marquis, NP Bosak, A Lysenko, MA Koshnevisan, ... Plos one 12 (12), e0188972, 2017 | 5 | 2017 |
| TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones LC Shaw, M Poussin, A Rodriguez-Garcia, J Eggold, NG Minutolo, ... Blood Advances 7 (9), 1885-1898, 2023 | 4 | 2023 |
| A novel approach for the treatment of T cell malignancies: targeting T cell receptor Vβ families J Wang, K Urbanska, P Sharma, R Nejati, L Shaw, MS Lim, SJ Schuster, ... Vaccines 8 (4), 631, 2020 | 4 | 2020 |
| Limited Immunogenicity of an HLA-A* 03: 01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in Cancer EE Grundy, LC Shaw, L Wang, DJ Powell, M Ostrowski, RB Jones, ... | | 2024 |
| 1514 In vivo CAR-M: redirecting endogenous myeloid cells with mRNA for cancer immunotherapy B Varghese, S Mori, S Pierini, A Bagashev, Y Ohtani, R Gabbasov, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
| Compositions and methods of t cell receptor vb family member targeting for the treatment of t cell associated disease DJ Powell, SJ Schuster, L Shaw US Patent App. 17/759,679, 2023 | | 2023 |
| Development of Two Novel Chimeric Antigen Receptor Platforms to Advance the Control and Specificity of Next-Generation T Cell Therapies LC Shaw University of Pennsylvania, 2022 | | 2022 |
| Adiposity QTL Adip20 C Lin, BD Fesi, M Marquis, NP Bosak, A Lysenko, M Amin, ... | | |
